Pradaxa and Spiriva generic in 2018!

You can watch the replay anytime.

 

THis is 100% accurate and a perfect summary of the future of BI. As the post says, nothing much left to sell after 2020 outside of diabetes and OFEV. Watch the town halls over the next year or so and it's all there for you to see yourself.

 

OFEV will be ramping down in the upcoming year. Genentech has already recognized the ceiling of this disease state. Started downsizing this month. Don’t worry the asperger like leadership will easily be a year behind the curve. Reps drive around aimlessly and hawk out Pulmonary clinics for a marginal patient
Territories will soon become as rare as the disease. Hope everyone enjoyed the big trips. Next year maybe Detroit

 

Poor leadership led to the fall of this once great company